Synaptic proteins, neuropathology and cognitive status in the oldest-old

Neurobiology of Aging

Volumn 30, Issue 7, 2009, Pages 1125-1134

  Head, Elizabeth ^a,b   Corrada, Maria M ^a,b   Kahle Wrobleski, Kristin ^a   Kim, Ronald C ^a   Sarsoza, Floyd ^a   Goodus, Matthew ^a   Kawas, Claudia H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinico pathology correlation; Cognitively impaired not demented; Compensatory response; Dementia; Growth associated protein 43 (GAP 43); MMSE; Oldest old; Postsynaptic density (PSD); Synaptophysin (SYN)

Indexed keywords

NEUROMODULIN; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPTOPHYSIN;

AGED; AGING; ARTICLE; AUTOPSY; CELL FUNCTION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MALE; MINI MENTAL STATE EXAMINATION; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DEPLETION; SENILE PLAQUE;

AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; COGNITION DISORDERS; COHORT STUDIES; DEMENTIA; DISEASE PROGRESSION; FEMALE; FRONTAL LOBE; GAP-43 PROTEIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; SYNAPTIC MEMBRANES; SYNAPTOPHYSIN;

EID: 65649120085     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.10.001     Document Type: Article

References (56)

1. Akram A., Christoffel D., Rocher A.B., Bouras C., Kovari E., Perl D.P., Morrison J.H., Herrmann F.R., Haroutunian V., Giannakopoulos P., and Hof P.R. Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: relationship with the progression of Alzheimer's disease. Neurobiol. Aging (2007) 10.1016/j.neurobiolaging.2007.03.007
2. Alafuzoff L., Iqbal K., Friden H., Adolfsson R., and Winblad B. Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate analysis. Acta Neuropathol. (Berl.) 74 (1987) 209-225
3. Alford M.F., Masliah E., Hansen L.A., and Terry R.D. A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain. J. Histochem. Cytochem. 42 2 (1994) 283-287
4. Almeida C.G., Tampellini D., Takahashi R.H., Greengard P., Lin M.T., Snyder E.M., and Gouras G.K. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 20 2 (2005) 187-198
5. Association A.P. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
6. Benowitz L.I., Perrone-Bizzozero N.I., and Finklestein S.P. Molecular properties of the growth-associated protein GAP-43 (B-50). J. Neurochem. 48 5 (1987) 1640-1647
7. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82 4 (1991) 239-259
8. Caccamo A., Oddo S., Billings L.M., Green K.N., Martinez-Coria H., Fisher A., and LaFerla F.M. M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49 5 (2006) 671-682
9. Callahan L.M., Vaules W.A., and Coleman P.D. Progressive reduction of synaptophysin message in single neurons in Alzheimer disease. J. Neuropathol. Exp. Neurol. 61 5 (2002) 384-395
10. Coleman P.D., Kazee A.M., Lapham L., Eskin T., and Rogers K. Reduced GAP-43 message levels are associated with increased neurofibrillary tangle density in the frontal association cortex (area 9) in Alzheimer's disease. Neurobiol. Aging 13 6 (1992) 631-639
11. Counts S.E., Nadeem M., Lad S.P., Wuu J., and Mufson E.J. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J. Neuropathol. Exp. Neurol. 65 6 (2006) 592-601
12. Crystal H., Dickson D., Fuld P., Masur D., Scott R., Mehler M., Masdeu J., Kawas C., Aronson M., and Wolfson L. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 38 (1988) 1682-1687
13. Crystal H.A., Dickson D., Davies P., Masur D., Grober E., and Lipton R.B. The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Arch. Neurol. 57 5 (2000) 713-719
14. Cummings B.J., Pike C.J., Shankle R., and Cotman C.W. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol. Aging 17 6 (1996) 921-933
15. Dayan A.D. Quantitative histological studies on the aged human brain. II. Senile plaques and neurofibrillary tangles in senile dementia (with an appendix on the occurrence in cases of carcinoma). Acta Neuropathol. (Berl.) 16 (1970) 95-102
16. DeKosky S.T., and Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27 5 (1990) 457-464
17. Dickson D.W., Crystal H.A., Bevona C., Honer W., Vincent I., and Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol. Aging 16 3 (1995) 285-304
18. Ebly E.M., Parhad I.M., Hogan D.B., and Fung T.S. Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology 44 9 (1994) 1593-1600
19. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state: a practical method for grading the cognitive status of patients for the clinician. J. Psychiatry Res. 12 (1975) 189-198
20. Giannakopoulos P., Hof P.R., Vallet P.G., Giannakopoulos A.S., Charnay Y., and Bouras C. Quantitative analysis of neuropathologic changes in the cerebral cortex of centenarians. Prog. Neuropsychopharmacol. Biol. Psychiatry 19 4 (1995) 577-592
21. Giannakopoulos P., Hof P.R., Kovari E., Vallet P.G., Herrmann F.R., and Bouras C. Distinct patterns of neuronal loss and Alzheimer's disease lesion distribution in elderly individuals older than 90 years. J. Neuropathol. Exp. Neurol. 55 12 (1996) 1210-1220
22. Gold G., Bouras C., Kovari E., Canuto A., Glaria B.G., Malky A., Hof P.R., Michel J.P., and Giannakopoulos P. Clinical validity of Braak neuropathological staging in the oldest-old. Acta Neuropathol. (Berl.) 99 5 (2000) 579-582 (Discussion, pp. 83-84)
23. Graves A.B., Larson E.B., Edland S.D., Bowen J.D., McCormick W.C., McCurry S.M., Rice M.M., Wenzlow A., and Uomoto J.M. Prevalence of dementia and its subtypes in the Japanese American population of King County. Washington state. The Kame Project. Am. J. Epidemiol. 144 8 (1996) 760-771
24. Green M.S., Kaye J.A., and Ball M.J. The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old. Neurology 54 1 (2000) 105-113
25. Gylys K.H., Fein J.A., Yang F., Wiley D.J., Miller C.A., and Cole G.M. Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Am. J. Pathol. 165 5 (2004) 1809-1817
26. Head E., Starr A., Kim R.C., Parachikova A., Lopez G.E., Dick M., and Cribbs D.H. Relapsing polychondritis with features of dementia with Lewy bodies. Acta Neuropathol. (Berl.) 112 2 (2006) 217-225
27. Heinonen O., Soininen H., Sorvari H., Kosunen O., Paljarvi L., Koivisto E., and Riekkinen Sr. P.J. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience 64 2 (1995) 375-384
28. Honer W.G., Dickson D.W., Gleeson J., and Davies P. Regional synaptic pathology in Alzheimer's disease. Neurobiol. Aging 13 3 (1992) 375-382
29. Ingelsson M., Fukumoto H., Newell K.L., Growdon J.H., Hedley-Whyte E.T., Frosch M.P., Albert M.S., Hyman B.T., and Irizarry M.C. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62 6 (2004) 925-931
30. Jorm A.F., Korten A.E., and Henderson A.S. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr. Scand. 76 5 (1987) 465-479
31. Katzman R., Terry R., DeTeresa R., Brown T., Davis P., Fuld P., Renbing X., and Peck A. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23 (1988) 138-144
32. Langui D., Probst A., and Ulrich J. Alzheimer's changes in non-demented and demented patients: a statistical approach to their relationships. Acta Neuropathol. 89 (1995) 57-62
33. Lassmann H., Weiler R., Fischer P., Bancher C., Jellinger K., Floor E., Danielczyk W., Seitelberger F., and Winkler H. Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles. Neuroscience 46 1 (1992) 1-8
34. Love S., Siew L.K., Dawbarn D., Wilcock G.K., Ben-Shlomo Y., and Allen S.J. Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiol. Aging 27 6 (2006) 797-803
35. Lue L.F., Brachova L., Civin W.H., Rogers J., and Inflammation. A-beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J. Neuropathol. Exp. Neurol. 55 (1996) 1083
36. Lue L.F., Kuo Y.M., Roher A.E., Brachova L., Shen Y., Sue L., Beach T., Kurth J.H., Rydel R.E., and Rogers J. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155 3 (1999) 853-862
37. Masliah E., Terry R.D., DeTeresa R.M., and Hansen L.A. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci. Lett. 103 2 (1989) 234-239
38. Masliah E., Mallory M., Hansen L., Alford M., Albright T., DeTeresa R., Terry R., Baudier J., and Saitoh T. Patterns of aberrant sprouting in Alzheimer's disease. Neuron 6 5 (1991) 729-739
39. Masliah E., Terry R.D., Alford M., DeTeresa R., and Hansen L.A. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am. J. Pathol. 138 1 (1991) 235-246
40. Masliah E., Mallory M., Alford M., DeTeresa R., Hansen L.A., McKeel Jr. D.W., and Morris J.C. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 56 1 (2001) 127-129
41. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
42. Migaud M., Charlesworth P., Dempster M., Webster L.C., Watabe A.M., Makhinson M., He Y., Ramsay M.F., Morris R.G., Morrison J.H., O'Dell T.J., and Grant S.G. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 396 6710 (1998) 433-439
43. Price J.L., Davis P.B., Morris J.C., and White D.L. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging 12 (1991) 295-312
44. Reddy P.H., Mani G., Park B.S., Jacques J., Murdoch G., Whetsell Jr. W., Kaye J., and Manczak M. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J. Alzheimers Dis. 7 2 (2005) 103-117 (Discussion, pp. 73-80)
45. Riley K.P., Snowdon D.A., and Markesbery W.R. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann. Neurol. 51 5 (2002) 567-577
46. Scheff S.W., and Price D.A. Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol. Aging 24 8 (2003) 1029-1046
47. Scheff S.W., Price D.A., Schmitt F.A., and Mufson E.J. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 27 10 (2006) 1372-1384
48. Silver M., Newell K., Hyman B., Growdon J., Hedley-Whyte E.T., and Perls T. Unraveling the mystery of cognitive changes in old age: correlation of neuropsychological evaluation with neuropathological findings in the extreme old. Int. Psychogeriatr. 10 1 (1998) 25-41
49. Silver M.H., Newell K., Brady C., Hedley-White E.T., and Perls T.T. Distinguishing between neurodegenerative disease and disease-free aging: correlating neuropsychological evaluations and neuropathological studies in centenarians. Psychosom. Med. 64 3 (2002) 493-501
50. Skene H. Axonal growth-associated proteins. Annu. Rev. Neurosci. 12 (1989) 127-156
51. Spires T.L., Meyer-Luehmann M., Stern E.A., McLean P.J., Skoch J., Nguyen P.T., Bacskai B.J., and Hyman B.T. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J. Neurosci. 25 31 (2005) 7278-7287
52. Sze C.-I., Troncoso J.C., Kawas C., Mouton P., Price D.L., and Martin L.J. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 56 8 (1997) 933-944
53. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., and Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30 (1991) 572-580
54. von Strauss E., Viitanen M., De Ronchi D., Winblad B., and Fratiglioni L. Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch. Neurol. 56 5 (1999) 587-592
55. Whittle C., Corrada M.M., Dick M., Ziegler R., Kahle-Wrobleski K., Paganini-Hill A., and Kawas C. Neuropsychological data in nondemented oldest old: The 90+ Study. J. Clin. Exp. Neuropsychol. 29 3 (2007) 290-299
56. Wiedenmann B., and Franke W.W. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41 3 (1985) 1017-1028